du Toit D F, Leith J G, Strauss D C, Blaszczyk M, Odendaal J de V, Warren B L
Department of Surgery, Tygerberg Hospital and the University of Stellenbosch, Tygerberg, South Africa.
Br J Surg. 2003 Dec;90(12):1516-21. doi: 10.1002/bjs.4343.
This study evaluated a single-centre experience with endovascular repair of traumatic arteriovenous fistula in the cervicothoracic region.
Endovascular repair of 27 traumatic cervicothoracic arteriovenous fistulas was attempted between August 1998 and December 2001. Patients with active bleeding or end-organ ischaemia were excluded. Follow-up was accomplished with clinical, duplex Doppler and arteriographic evaluation after 1 month and then every 3 months.
Twelve patients with a major vessel injury were treated by stent-graft placement. Vessels involved were the subclavian (eight), common carotid (three) and internal carotid (one) arteries. Subclavian artery side branches were embolized in three of the eight patients. Four patients developed early type 4 endoleaks but all resolved. Treatment with stent-grafts was ultimately successful in all 12 patients. Three patients were lost to follow-up. During mean follow-up of 21 (range 3-36) months, one of the remaining patients developed a graft stenosis. Fifteen patients with minor vessel injuries were treated with arterial embolization. Vessels embolized were subclavian artery branches (four), external carotid artery and branches (seven) and vertebral arteries (four). Successful embolization was accomplished in ten of 15 patients.
Endovascular therapy is a promising alternative to surgery for selected patients with cervicothoracic arteriovenous fistula.
本研究评估了在单一中心对颈胸段创伤性动静脉瘘进行血管腔内修复的经验。
1998年8月至2001年12月期间,尝试对27例颈胸段创伤性动静脉瘘进行血管腔内修复。排除有活动性出血或终末器官缺血的患者。术后1个月进行临床、双功多普勒和血管造影评估,随后每3个月进行一次随访。
12例主要血管损伤患者接受了支架移植物置入治疗。受累血管包括锁骨下动脉(8例)、颈总动脉(3例)和颈内动脉(1例)。8例患者中有3例的锁骨下动脉分支进行了栓塞。4例患者出现早期4型内漏,但均已消失。12例患者最终均成功接受了支架移植物治疗。3例患者失访。在平均21(3 - 36)个月的随访期间,其余患者中有1例出现移植物狭窄。15例小血管损伤患者接受了动脉栓塞治疗。栓塞的血管包括锁骨下动脉分支(4例)、颈外动脉及其分支(7例)和椎动脉(4例)。15例患者中有10例成功进行了栓塞。
对于部分颈胸段动静脉瘘患者,血管腔内治疗是一种有前景的手术替代方案。